Arai, Alshera M.

HRN: 24-48-57  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/08/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
02/08/2025
02/15/2025
IV DRIP
400 Mg
Q6H
Carbunculosis, AGE
Waiting Final Action 
02/08/2025
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
02/08/2025
02/14/2025
PO
3ml
TID
Amoebiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: